109 related articles for article (PubMed ID: 36950886)
1. Structural and functional characterization of SARS-CoV-2 nucleocapsid protein mutations identified in Turkey by using in silico approaches.
Akcesme B; Erkal B; Donmez ZY
Acta Virol; 2023; 67(1):59-68. PubMed ID: 36950886
[TBL] [Abstract][Full Text] [Related]
2. Modulation of biophysical properties of nucleocapsid protein in the mutant spectrum of SARS-CoV-2.
Nguyen A; Zhao H; Myagmarsuren D; Srinivasan S; Wu D; Chen J; Piszczek G; Schuck P
Elife; 2024 Jun; 13():. PubMed ID: 38941236
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 variants with T135I nucleocapsid mutations may affect antigen test performance.
Jian MJ; Chung HY; Chang CK; Lin JC; Yeh KM; Chen CW; Lin DY; Chang FY; Hung KS; Perng CL; Shang HS
Int J Infect Dis; 2022 Jan; 114():112-114. PubMed ID: 34758391
[TBL] [Abstract][Full Text] [Related]
4. Contributions of the N-terminal intrinsically disordered region of the severe acute respiratory syndrome coronavirus 2 nucleocapsid protein to RNA-induced phase separation.
Zachrdla M; Savastano A; Ibáñez de Opakua A; Cima-Omori MS; Zweckstetter M
Protein Sci; 2022 Sep; 31(9):e4409. PubMed ID: 36040256
[TBL] [Abstract][Full Text] [Related]
5. In silico characterization of mutations circulating in SARS-CoV-2 structural proteins.
Periwal N; Rathod SB; Pal R; Sharma P; Nebhnani L; Barnwal RP; Arora P; Srivastava KR; Sood V
J Biomol Struct Dyn; 2022 Nov; 40(18):8216-8231. PubMed ID: 33797336
[TBL] [Abstract][Full Text] [Related]
6. Comparative genome analysis of novel coronavirus (SARS-CoV-2) from different geographical locations and the effect of mutations on major target proteins: An in silico insight.
Khan MI; Khan ZA; Baig MH; Ahmad I; Farouk AE; Song YG; Dong JJ
PLoS One; 2020; 15(9):e0238344. PubMed ID: 32881907
[TBL] [Abstract][Full Text] [Related]
7. Identification and functional analysis of the SARS-COV-2 nucleocapsid protein.
Gao T; Gao Y; Liu X; Nie Z; Sun H; Lin K; Peng H; Wang S
BMC Microbiol; 2021 Feb; 21(1):58. PubMed ID: 33618668
[TBL] [Abstract][Full Text] [Related]
8. Evolution of SARS-CoV-2 Envelope, Membrane, Nucleocapsid, and Spike Structural Proteins from the Beginning of the Pandemic to September 2020: A Global and Regional Approach by Epidemiological Week.
Troyano-Hernáez P; Reinosa R; Holguín Á
Viruses; 2021 Feb; 13(2):. PubMed ID: 33557213
[TBL] [Abstract][Full Text] [Related]
9. A comprehensive genomic study, mutation screening, phylogenetic and statistical analysis of SARS-CoV-2 and its variant omicron among different countries.
Ahmad SU; Hafeez Kiani B; Abrar M; Jan Z; Zafar I; Ali Y; Alanazi AM; Malik A; Rather MA; Ahmad A; Khan AA
J Infect Public Health; 2022 Aug; 15(8):878-891. PubMed ID: 35839568
[TBL] [Abstract][Full Text] [Related]
10. Impact of mutations on the stability of SARS-CoV-2 nucleocapsid protein structure.
Muradyan N; Arakelov V; Sargsyan A; Paronyan A; Arakelov G; Nazaryan K
Sci Rep; 2024 Mar; 14(1):5870. PubMed ID: 38467657
[TBL] [Abstract][Full Text] [Related]
11. Evolutionary dynamics of SARS-CoV-2 nucleocapsid protein and its consequences.
Rahman MS; Islam MR; Alam ASMRU; Islam I; Hoque MN; Akter S; Rahaman MM; Sultana M; Hossain MA
J Med Virol; 2021 Apr; 93(4):2177-2195. PubMed ID: 33095454
[TBL] [Abstract][Full Text] [Related]
12. Evaluation on the use of Nanopore sequencing for direct characterization of coronaviruses from respiratory specimens, and a study on emerging missense mutations in partial RdRP gene of SARS-CoV-2.
Chan WS; Au CH; Lam HY; Wang CLN; Ho DN; Lam YM; Chu DKW; Poon LLM; Chan TL; Zee JS; Ma ESK; Tang BSF
Virol J; 2020 Nov; 17(1):183. PubMed ID: 33225958
[TBL] [Abstract][Full Text] [Related]
13. Discriminative electrochemical biosensing of wildtype and omicron variant of SARS-CoV-2 nucleocapsid protein with single platform.
Liv L; Baş A
Anal Biochem; 2022 Nov; 657():114898. PubMed ID: 36100035
[TBL] [Abstract][Full Text] [Related]
14. Trinucleotide Substitutions at Two Locations in the SARS-CoV-2 Nucleocapsid (N) Gene.
Akaishi T; Fujiwara K; Ishii T
Tohoku J Exp Med; 2023 May; 260(1):21-27. PubMed ID: 36792177
[TBL] [Abstract][Full Text] [Related]
15. GCG inhibits SARS-CoV-2 replication by disrupting the liquid phase condensation of its nucleocapsid protein.
Zhao M; Yu Y; Sun LM; Xing JQ; Li T; Zhu Y; Wang M; Yu Y; Xue W; Xia T; Cai H; Han QY; Yin X; Li WH; Li AL; Cui J; Yuan Z; Zhang R; Zhou T; Zhang XM; Li T
Nat Commun; 2021 Apr; 12(1):2114. PubMed ID: 33837182
[TBL] [Abstract][Full Text] [Related]
16. RG203KR Mutations in SARS-CoV-2 Nucleocapsid: Assessing the Impact Using a Virus-Like Particle Model System.
Raheja H; Das S; Banerjee A; P D; C D; Mukhopadhyay D; Ramachandra SG; Das S
Microbiol Spectr; 2022 Aug; 10(4):e0078122. PubMed ID: 35862952
[TBL] [Abstract][Full Text] [Related]
17. Retrospective in silico mutation profiling of SARS-CoV-2 structural proteins circulating in Uganda by July 2021: Towards refinement of COVID-19 disease vaccines, diagnostics, and therapeutics.
Odongo S; Okella H; Ndekezi C; Okee M; Namayanja M; Mujuni B; Sterckx YGJ; Kizito D; Radwanska M; Magez S; Ikwap K; Mwiine FN; Lutwama JJ; Ibingira C
PLoS One; 2022; 17(12):e0279428. PubMed ID: 36548384
[TBL] [Abstract][Full Text] [Related]
18. Rapid Biosensor of SARS-CoV-2 Using Specific Monoclonal Antibodies Recognizing Conserved Nucleocapsid Protein Epitopes.
Lee JH; Jung Y; Lee SK; Kim J; Lee CS; Kim S; Lee JS; Kim NH; Kim HG
Viruses; 2022 Jan; 14(2):. PubMed ID: 35215848
[TBL] [Abstract][Full Text] [Related]
19. Recombinant highly antigenic truncated fusion-based protein as a diagnostic antigen for anti-SARS-CoV-2 nucleocapsid antibody ELISA.
Salarifar A; Khalili S; Rasaee MJ
Protein Expr Purif; 2023 Mar; 203():106200. PubMed ID: 36379348
[TBL] [Abstract][Full Text] [Related]
20. Effects of SARS-CoV-2 mutations on protein structures and intraviral protein-protein interactions.
Wu S; Tian C; Liu P; Guo D; Zheng W; Huang X; Zhang Y; Liu L
J Med Virol; 2021 Apr; 93(4):2132-2140. PubMed ID: 33090512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
